| SC 13G | 2024-03-18 | GLAZER CAPITAL, LLC | Harpoon Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2024-03-13 | GAMCO INVESTORS, INC. ET AL | Harpoon Therapeutics, Inc. | - | 0.0% | EDGAR |
| SC 13D/A | 2024-03-11 | MERCK SHARP & DOHME LLC | Harpoon Therapeutics, Inc. | 1,000 | 100.0% | EDGAR |
| SC 13D | 2024-02-27 | GAMCO INVESTORS, INC. ET AL | Harpoon Therapeutics, Inc. | 862,549 | 4.0% | EDGAR |
| SC 13D/A | 2024-02-21 | Arix Bioscience plc | Harpoon Therapeutics, Inc. | 323,893 | 1.5% | EDGAR |
| SC 13G/A | 2024-02-14 | RA CAPITAL MANAGEMENT, L.P. | Harpoon Therapeutics, Inc. | 1,712,792 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Harpoon Therapeutics, Inc. | - | 5.9% | EDGAR |
| SC 13G/A | 2024-02-13 | New Leaf Ventures III, L.P. | Harpoon Therapeutics, Inc. | 481,533 | - | EDGAR |
| SC 13G | 2024-02-13 | VANGUARD GROUP INC | Harpoon Therapeutics, Inc. | 880,017 | 5.2% | EDGAR |
| SC 13D/A | 2024-02-12 | MPM BioVentures 2014, L.P. | Harpoon Therapeutics, Inc. | 265,709 | 1.6% | EDGAR |
| SC 13G/A | 2024-02-09 | Artal International S.C.A. | Harpoon Therapeutics, Inc. | 2,038,870 | 9.9% | EDGAR |
| SC 13G/A | 2024-02-06 | Soleus Private Equity Fund III, L.P. | Harpoon Therapeutics, Inc. | 1,537,312 | 8.5% | EDGAR |
| SC 13G/A | 2024-01-19 | INTEGRATED CORE STRATEGIES (US) LLC | Harpoon Therapeutics, Inc. | 25,465 | 0.0% | EDGAR |
| SC 13D | 2024-01-18 | MERCK SHARP & DOHME LLC | Harpoon Therapeutics, Inc. | 3,080,815 | 17.5% | EDGAR |
| SC 13G | 2023-11-06 | Cormorant Asset Management, LP | Harpoon Therapeutics, Inc. | 1,624,559 | - | EDGAR |
| SC 13G | 2023-11-06 | RA CAPITAL MANAGEMENT, L.P. | Harpoon Therapeutics, Inc. | 1,701,570 | 10.0% | EDGAR |
| SC 13G | 2023-11-06 | CITADEL ADVISORS LLC | Harpoon Therapeutics, Inc. | - | 6.0% | EDGAR |
| SC 13G | 2023-11-03 | COMMODORE CAPITAL LP | Harpoon Therapeutics, Inc. | 1,703,465 | 9.9% | EDGAR |
| SC 13G | 2023-10-26 | Soleus Private Equity Fund III, L.P. | Harpoon Therapeutics, Inc. | 1,537,312 | 8.5% | EDGAR |
| SC 13G | 2023-03-31 | Artal International S.C.A. | Harpoon Therapeutics, Inc. | 2,347,437 | 6.1% | EDGAR |